Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 4Other 3Genitourinary 3Lymphoid 2Thoracic 1Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Skin Neoplasms 1Dermatitis, Contact 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Docosahexaenoic Acids × Dermatologic × Clear all
NCT01032343 2013-08-22

An Immunonutritional Approach to the Prevention of Skin Cancer

University of Manchester

Phase NA Completed
90 enrolled
Dermatologic

Dermatitis, Contact, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡